RUTI Immune — Seed (estimated) · €1.6M

RUTI Immune, an Archivel Farma subsidiary developing the RUTI trained-immunity vaccine against COVID-19, raised €1.61M from 839 investors on Capital Cell, including an unnamed Spanish lead investor who put in €600K.

Lead not disclosed RoundSeed (estimated) Announced19 Jan 2021 CityBadalona SectorHealthtech & Bio · Biotech Source W

Something wrong? Suggest a correction →